Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

  • Quoted phrase not found.
1.

Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time.

Shipley MM, Renner DW, Ott M, Bloom DC, Koelle DM, Johnston C, Szpara ML.

J Infect Dis. 2018 Jul 13;218(4):595-605. doi: 10.1093/infdis/jiy216.

PMID:
29920588
2.

Immunization by replication-competent controlled herpesvirus vectors.

Bloom DC, Tran RK, Feller J, Voellmy R.

J Virol. 2018 Jun 13. pii: JVI.00616-18. doi: 10.1128/JVI.00616-18. [Epub ahead of print]

3.

In vivo Knock-down of the HSV-1 Latency-Associated Transcript Reduces Reactivation from Latency.

Watson ZL, Washington SD, Phelan DM, Lewin AS, Tuli SS, Schultz GS, Neumann DM, Bloom DC.

J Virol. 2018 Jun 6. pii: JVI.00812-18. doi: 10.1128/JVI.00812-18. [Epub ahead of print]

PMID:
29875240
4.

Depletion of the insulator protein CTCF results in HSV-1 reactivation in vivo.

Washington SD, Edenfield SI, Lieux C, Watson ZL, Taasan SM, Dhummakupt A, Bloom DC, Neumann DM.

J Virol. 2018 Mar 7. pii: JVI.00173-18. doi: 10.1128/JVI.00173-18. [Epub ahead of print]

PMID:
29514910
5.

The ATM and Rad3-Related (ATR) Protein Kinase Pathway Is Activated by Herpes Simplex Virus 1 and Required for Efficient Viral Replication.

Edwards TG, Bloom DC, Fisher C.

J Virol. 2018 Feb 26;92(6). pii: e01884-17. doi: 10.1128/JVI.01884-17. Print 2018 Mar 15.

PMID:
29263259
6.

Reliable Detection of Herpes Simplex Virus Sequence Variation by High-Throughput Resequencing.

Morse AM, Calabro KR, Fear JM, Bloom DC, McIntyre LM.

Viruses. 2017 Aug 16;9(8). pii: E226. doi: 10.3390/v9080226.

7.

Development of Recombinant HSV-Based Vaccine Vectors.

Voellmy R, Bloom DC, Vilaboa N, Feller J.

Methods Mol Biol. 2017;1581:55-78. doi: 10.1007/978-1-4939-6869-5_4.

PMID:
28374243
8.

HSV1 latent transcription and non-coding RNA: A critical retrospective.

Phelan D, Barrozo ER, Bloom DC.

J Neuroimmunol. 2017 Jul 15;308:65-101. doi: 10.1016/j.jneuroim.2017.03.002. Epub 2017 Mar 6. Review.

PMID:
28363461
9.

Comparison of three cell-based drug screening platforms for HSV-1 infection.

D'Aiuto L, Williamson K, Dimitrion P, McNulty J, Brown CE, Dokuburra CB, Nielsen AJ, Lin WJ, Piazza P, Schurdak ME, Wood J, Yolken RH, Kinchington PR, Bloom DC, Nimgaonkar VL.

Antiviral Res. 2017 Jun;142:136-140. doi: 10.1016/j.antiviral.2017.03.016. Epub 2017 Mar 23.

10.

Adeno-associated Virus Vectors Efficiently Transduce Mouse and Rabbit Sensory Neurons Coinfected with Herpes Simplex Virus 1 following Peripheral Inoculation.

Watson ZL, Ertel MK, Lewin AS, Tuli SS, Schultz GS, Neumann DM, Bloom DC.

J Virol. 2016 Aug 12;90(17):7894-901. doi: 10.1128/JVI.01028-16. Print 2016 Sep 1.

11.

Alphaherpesvirus Latency: A Dynamic State of Transcription and Reactivation.

Bloom DC.

Adv Virus Res. 2016;94:53-80. doi: 10.1016/bs.aivir.2015.10.001. Epub 2016 Feb 15. Review.

PMID:
26997590
12.

Simultaneous visualization of two Citrus tristeza virus genotypes provides new insights into the structure of multi-component virus populations in a host.

Bergua M, Phelan DM, Bak A, Bloom DC, Folimonova SY.

Virology. 2016 Apr;491:10-9. doi: 10.1016/j.virol.2016.01.017. Epub 2016 Feb 9.

13.

Herpes simplex virus type-1: replication, latency, reactivation and its antiviral targets.

Pires de Mello CP, Bloom DC, Paix√£o IC.

Antivir Ther. 2016;21(4):277-86. doi: 10.3851/IMP3018. Epub 2016 Jan 4. Review.

PMID:
26726828
14.

Replication-Competent Controlled Herpes Simplex Virus.

Bloom DC, Feller J, McAnany P, Vilaboa N, Voellmy R.

J Virol. 2015 Oct;89(20):10668-79. doi: 10.1128/JVI.01667-15. Epub 2015 Aug 12.

15.

A Genomic Approach to Unravel Host-Pathogen Interaction in Chelonians: The Example of Testudinid Herpesvirus 3.

Origgi FC, Tecilla M, Pilo P, Aloisio F, Otten P, Aguilar-Bultet L, Sattler U, Roccabianca P, Romero CH, Bloom DC, Jacobson ER.

PLoS One. 2015 Aug 5;10(8):e0134897. doi: 10.1371/journal.pone.0134897. eCollection 2015.

16.

Broad-spectrum non-nucleoside inhibitors of human herpesviruses.

McClain L, Zhi Y, Cheng H, Ghosh A, Piazza P, Yee MB, Kumar S, Milosevic J, Bloom DC, Arav-Boger R, Kinchington PR, Yolken R, Nimgaonkar V, D'Aiuto L.

Antiviral Res. 2015 Sep;121:16-23. doi: 10.1016/j.antiviral.2015.06.005. Epub 2015 Jun 12.

17.

A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus.

Voellmy R, Bloom DC, Vilaboa N.

Expert Rev Vaccines. 2015 May;14(5):637-51. doi: 10.1586/14760584.2015.1013941. Epub 2015 Feb 12. Review.

PMID:
25676927
18.

Inhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of herpes simplex virus 1 in trigeminal ganglion neurons.

Messer HG, Jacobs D, Dhummakupt A, Bloom DC.

J Virol. 2015 Mar;89(6):3417-20. doi: 10.1128/JVI.03052-14. Epub 2014 Dec 31.

19.

Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture.

Flores O, Nakayama S, Whisnant AW, Javanbakht H, Cullen BR, Bloom DC.

J Virol. 2013 Jun;87(12):6589-603. doi: 10.1128/JVI.00504-13. Epub 2013 Mar 27.

20.

LAT region factors mediating differential neuronal tropism of HSV-1 and HSV-2 do not act in trans.

Bertke AS, Apakupakul K, Ma A, Imai Y, Gussow AM, Wang K, Cohen JI, Bloom DC, Margolis TP.

PLoS One. 2012;7(12):e53281. doi: 10.1371/journal.pone.0053281. Epub 2012 Dec 31.

Supplemental Content

Loading ...
Support Center